Guoping Zheng is a researcher, whose documented academic activities include molecular biology, renal medicine, immunology and kidney disease research. His ORCID record identifies an academic career at the University of Sydney and provides information about his education, employment and scholarly publications.[1]
1. Abstract
This article presents the academic profile and research activities of Guoping Zheng. His documented scholarly work includes kidney fibrosis, renal inflammation, immune regulation and molecular signalling. The ORCID record lists 76 works and records his professional and educational history. Scopus information for this profile reports 106 documents, 6,791 citations and an h-index of 33. [2]
2. Keywords
Guoping Zheng; Best Researcher Award; Molecular Biology; Renal Medicine; Kidney Fibrosis; Immunology; Cellular Signalling; Research Impact; Medical Laboratory Science.
3. Introduction
Research in molecular biology contributes to understanding cellular mechanisms associated with human disease. Guoping Zheng’s documented publications address biological pathways involved in kidney injury, inflammation and tissue fibrosis. These subjects connect molecular mechanisms with clinically relevant questions in renal medicine and biomedical research. [1]
4. Research Profile
According to his ORCID record, Zheng has been associated with the University of Sydney since 2007, holding research and academic appointments, including Associate Professor from 2019. His education includes a PhD from the University of Sydney and earlier medical and medical science qualifications from Shanxi Medical University. His recorded professional experience also includes appointments at Westmead Hospital. [1]
5. Research Contributions
His publication record covers several interconnected research themes, including renal fibrosis, inflammatory responses, dendritic cell activity and transforming growth factor-beta signalling. Studies involving beta-catenin and FoxO signalling investigate mechanisms associated with kidney tissue repair and fibrosis. [3]
6. Publications
Guoping Zheng’s ORCID record highlights research in renal interstitial fibrosis, kidney injury, and cellular signalling. His publications include Promotion of β-catenin/Foxo1 signaling ameliorates renal interstitial fibrosis (2019), and Matrix metalloproteinase 9 induces endothelial-mesenchymal transition via Notch activation in human kidney glomerular endothelial cells (2016). [4]
7. Research Impact
The Scopus profile reports 6,791 citations and an h-index of 33 across 106 documents. These indicators offer quantitative information about the visibility and citation history of the indexed research output. Citation measures should be interpreted with consideration of publication dates, subject-area practices and database coverage. [2]
8. Award Suitability
The Best Researcher Award recognizes scholarly contributions, research productivity and documented academic influence. Zheng’s publication history, research themes and bibliometric indicators provide relevant information for consideration within this recognition category. Final award eligibility and selection should be determined through the event’s published criteria and independent evaluation. [1]
9. Conclusion
Guoping Zheng’s academic record reflects sustained involvement in biomedical research, particularly in molecular mechanisms associated with kidney disease, inflammation and fibrosis. His documented appointments, publications and bibliometric profile provide a basis for presenting his research career in the context of the Medical Lab Scientist Awards. [2]
10. External Links
11. References
- ORCID. (2026). Guoping Zheng: ORCID researcher record and works.
https://orcid.org/0000-0002-5551-4522
- Elsevier. (n.d.). Scopus author details: Guoping Zheng, Author ID 8698483700. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=8698483700
- Rao, P., et al. (2019). Promotion of β-catenin/Foxo1 signaling ameliorates renal interstitial fibrosis. Laboratory Investigation.
https://doi.org/10.1038/s41374-019-0276-z
- Zhao, Y., et al. (2016). Matrix metalloproteinase 9 induces endothelial-mesenchymal transition via Notch activation in human kidney glomerular endothelial cells. BMC Cell Biology.
https://doi.org/10.1186/s12860-016-0101-0
- Chen, T., et al. (2021). Conventional Type 1 Dendritic Cells (cDC1) in Human Kidney Diseases: Clinico-Pathological Correlations. Frontiers in Immunology.
https://doi.org/10.3389/fimmu.2021.635212